WMMDCA: Prediction of Drug Responses by Weight-Based Modular Mapping in Cancer Cell Lines

Research output: Contribution to journalArticlepeer-review

Abstract

Due to the high consumption of cost and time for experimental verification in clinical trials, drug response prediction by computational models have become important challenges. The existing drug response data in diverse cell lines enable prediction of potential sensitive associations. Here, we propose a weight-based modular mapping method, named as WMMDCA, to predict drug-cell line associations. The method fully considers the effects of drugs' chemical structural feature, and adds modular information into the network projection. Leave-one-out cross-validation was used to evaluate the predictive ability of WMMDCA, which showed the best performance among several state-of-the-art methods in not only the whole dataset but also the major tissue types of cell lines. Literature support of highly ranked potential associations was found manually, demonstrating the effectiveness of WMMDCA on drug response prediction.

Original languageEnglish
Pages (from-to)2733-2740
Number of pages8
JournalIEEE/ACM Transactions on Computational Biology and Bioinformatics
Volume18
Issue number6
DOIs
StatePublished - 2021
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Drug response prediction
  • cell line
  • drug

Fingerprint

Dive into the research topics of 'WMMDCA: Prediction of Drug Responses by Weight-Based Modular Mapping in Cancer Cell Lines'. Together they form a unique fingerprint.

Cite this